+ Increase Font Decrease Font Question 28 of 50 The AGACNP is evaluating a new patient, a 65-year-old woman with a history of type 2 diabetes mellitus (T2DM; diagnosed 25 years ago), hypertension, and high cholesterol. She has retinopathy, polyneuropathy, and gastroparesis as complications of past poor T2DM control. Current medications are: metformin Glucophage) 1,000 mg BID, glimepiride (Amaryl) 5 mg once daily, pioglitazone (Actos) 15 mg once daily, and liraglutide (Victoza) 1.2 mg once daily. She complains of early satiety, feeling nauseated most of the day, and upper abdominal pain. After additional questioning, the patient reports feeling fuller than normal after she eats small meals; she experiences accompanying bloating. Which one of the patient's medications does the AGACNP suspect may be contributing to her symptoms? O Metformin (Glucophage) O Glimepiride (Amaryl) O Pioglitazone (Actos) O Liraglutide (Victoza)